Breaking News

Stevens Institute Opens Drug Discovery Lab

By Kristin Brooks | January 16, 2014

Initiative employs former Roche personnel and donated equipment

The Center for Healthcare Innovation at Stevens Institute of Technology has opened the Biotechnology and Drug Discovery Laboratory, a new enterprise that will partner with Stevens faculty, students, and external academic and industry collaborators.
The initiative was established in part with a donation of equipment and supplies from Hoffmann-La Roche and support from the NJ Department of Labor, along with seven former Roche personnel who recently joined Stevens as faculty and researchers. Lab staff also includes three new professors with extensive R&D experience in pharma and biopharma labs.
According to Dr. Peter Tolias, professor and director of the Center for Healthcare Innovation, “The Stevens Institute of Technology is grateful to Roche for their generous support in helping to establish this new enterprise that gives our students an opportunity to gain practical experience in biotechnology and drug development.”
Dr. Tolias added, “Serving as a center for research in the areas of preclinical gene cloning and purification of therapeutic proteins, assay development and robotic drug screening, the lab also provides industry collaborators with a local academic partner for research and workforce training. The new Stevens laboratory also furthers efforts to nurture entrepreneurship, contributes to maintaining NJ as a pharmaceutical and biotechnology hub, and positions Stevens as a premier research university and industry partner for biotechnology and drug discovery.”

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016